today @davidasinclair is telling the world that he has achieved age reversal with chemical cocktails
he submitted the paper on June 30 & it was accepted on July 4 by a journal of which he is coeditor-in-chief
paper was sent to me 3 days ago by a reporter for comment
reporter was told it is a "groundbreaking study" & "the first chemical approach to reprogram cells to a younger state"
reason WSJ didn't cover that paper is that ppl have been reporting chemical compounds that drive conversion of cells to induced pluripotency for the last 10-15 years
all of the compounds in today's paper were previously reported by others, mostly in 2013
it is a known property of these compounds to change gene expression & epigenetic age--valproic acid, etc, are targeted at the epigenetic state--that is how they work
getting these readouts on cells is not a groundbreaking study on reversal of aging
high throughput assays to identify such chemical matter were originally described by Vendrell in 2012
unlike today's paper, Vendrell identified a new compound with their method 11 yrs ago
Sinclair claims that his chemical cocktail (actually chemical cocktails developed by others) do not change cell identity but they did not do single cell sequencing to evaluate cell identity--only bulk sequencing, which cannot address this question
what i found interesting is that David earlier retracted his claim that his recent Cell paper demonstrated tissue rejuvenation--in a now deleted tweet, he wrote to @Sri_Baqri @CellCellPress saying his words in the Cell paper were misunderstood
but in the new paper, he says that the Cell paper showed that the epigenome "can be reset via partial reprogramming to regain tissue function"
he even says "reverse aspects of aging and extend lifespan in mice, paralleling treatment with AAV-OSK"
!!!
testing the patience of the Cell editors. 1st, he overstated his conclusions in Cell. 2nd, he said he was misinterpreted. 3rd, he cited the Cell paper as extending lifespan, which he surely didn't do
so, in brief, david is publishing _other ppl's compounds_ to do chemical reprogramming
he _did not test_ whether the compounds change cellular identity
yet he is _claiming groundbreaking results_ in this paper and in Cell that just aren't there
• • •
Missing some Tweet in this thread? You can try to
force a refresh
there's a peer review failure today doi.org/10.1016/j.cell… in which an individual with 59 collaborators claims to have tested the information theory of aging
he did not test the information theory of aging
the claim is that he induced dsDNA breaks that are easily repaired, don't cause a DNA damage response or mutagenesis or cell death--only an epigenetic change
he knows this is not true because his co-first author & he published this paper in dec '21
there are a few issues being addressed here. let’s start w safety
human placebo controlled trials have never shown adverse events attributable to Niagen. note that LDL-C is raised in humans w Basis & pterostilbene alone
the class of compounds to which NR belongs is vitamin B3
there are decades of human data on these molecules showing human safety. niacin is unique in causing flushing but nicotinamide was tested in large Australian skin cancer and was shown to be cancer-preventative in ppl
there’s a hierarchy of evidence w human RCTs (and meta-analysis of RCTs) on the top. human case reports & good quality rodent studies are lower. cell studies are lower. poorly conducted rodent and/or poorly conducted cell studies are garbage in/garbage out
faculty & trainees are consistently astonished by the house of cards built by influencers
so many ppl have been drawn into this by stories, model bias, confirmation bias & obfuscation
i will release a 1 hr version of the lecture
it's updated wrt monogenic longevity genes. while sirtuins are clearly not monogenic longevity genes even in yeast,
daf-2 & other genes in GH signaling for sure confer long-lived phenotypes w loss of function
these are genes conserved for _growth_, not for longevity, so i continue to hold that there are no dominantly acting monogenic longevity genes in mammals